Drugs / CG 8020
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00245362 | Jun 2002 → Jun 2004 | malignant pancreatic neoplasm | Cell Genesys | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CG 8020 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00245362 ↗ |